EasyDNNNews

Simple interventions reduce mammography recall rates

Tuesday, August 8, 2017
A few simple interventions can significantly reduce recall rates for both full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT), according to a study published online July 28 in Academic Radiology. And the interventions don't add much more time to a busy practice's workload, researchers found

Are older women getting appropriate mammo screening?

Monday, August 7, 2017
Older breast cancer survivors with a life expectancy of five years or less are continuing to receive annual surveillance mammography, according to a study published online July 27 in the Journal of Clinical Oncology.

Radiologists can trust DBT density measurements

Thursday, August 3, 2017
Breast density measurements calculated on full-field digital mammography (FFDM) and digital breast tomosynthesis (DBT) are comparable -- and so are median radiation dose values for dense breasts, according to a study published in the July issue of Academic Radiology.

Many Older Breast Cancer Survivors With Short Life Expectancy Go For Surveillance Mammography Each Year.

Wednesday, August 2, 2017

HealthImaging (8/1, Pearson) reports that research indicates that “despite known risks and unknown benefits, many older survivors of breast cancer with short life expectancy go for surveillance mammography every year.” Investigators also found that “relatively few with robust life expectancy don’t seem to bother.” The findings were published online in the Journal of Clinical Oncology.

Women Who Pay Out-Of-Pocket May Be Less Likely To Choose DBT Over Digital Mammography, Study Suggests.

Tuesday, August 1, 2017

Aunt Minnie (8/1, Yee) reports women who have to pay out-of-pocket “are less likely to choose digital breast tomosynthesis (DBT) over digital mammography, compared with women who have complete insurance coverage for the exam, according to a study published” in the Journal of the American College of Radiology. The researchers concluded that providers must demonstrate that DBT is worth the “additional cost to patients.”

RSS
First45679111213Last

Theme picker